Back to top

Sanofi investors likely to view new R&D head as a positive, says BofA

After Sanofi (SNY) announced a new head of R&D with Paulo Fontoura replacing Houman Ashrafian, BofA analyst Sachin Jain says investors are likely t...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Roche Holding AG (RHHBY)

Rogers Corporation (ROG)

Roper Technologies, Inc. (ROP)

Banco Santander, S.A. (SAN)

Sanofi (SNY)